As of 2024-12-12, the Relative Valuation of Biosynex SA (ALBIO.PA) is (2.89) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.73 EUR, the upside of Biosynex SA based on Relative Valuation is -267.2%.
The range of the Relative Valuation is (2.89) - (23.21) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.8x - 6.4x | 1.0x |
| Forward P/E multiples | 0.5x - 6.4x | 0.6x |
| Fair Price | (2.89) - (23.21) | (2.89) |
| Upside | -267.2% - -1441.6% | -267.2% |
| Date | P/E |
| 2024-11-29 | -0.72 |
| 2024-11-28 | -0.72 |
| 2024-11-27 | -0.74 |
| 2024-11-26 | -0.76 |
| 2024-11-25 | -0.77 |
| 2024-11-22 | -0.77 |
| 2024-11-21 | -0.80 |
| 2024-11-20 | -0.78 |
| 2024-11-19 | -0.79 |
| 2024-11-18 | -0.79 |
| 2024-11-15 | -0.76 |
| 2024-11-14 | -0.75 |
| 2024-11-13 | -0.78 |
| 2024-11-12 | -0.80 |
| 2024-11-11 | -0.81 |
| 2024-11-08 | -0.76 |
| 2024-11-07 | -0.81 |
| 2024-11-06 | -0.80 |
| 2024-11-05 | -0.80 |
| 2024-11-04 | -0.83 |
| 2024-11-01 | -0.77 |
| 2024-10-31 | -0.76 |
| 2024-10-30 | -0.75 |
| 2024-10-29 | -0.84 |
| 2024-10-28 | -0.88 |
| 2024-10-25 | -0.89 |
| 2024-10-24 | -0.93 |
| 2024-10-23 | -0.91 |
| 2024-10-22 | -0.91 |
| 2024-10-21 | -0.94 |
| 2024-10-18 | -0.97 |
| 2024-10-17 | -1.19 |
| 2024-10-16 | -1.19 |
| 2024-10-15 | -1.23 |
| 2024-10-14 | -1.24 |
| 2024-10-11 | -1.27 |
| 2024-10-10 | -1.26 |
| 2024-10-09 | -1.27 |
| 2024-10-08 | -1.29 |
| 2024-10-07 | -1.28 |
| 2024-10-04 | -1.28 |
| 2024-10-03 | -1.28 |
| 2024-10-02 | -1.21 |
| 2024-10-01 | -1.17 |
| 2024-09-30 | -1.15 |
| 2024-09-27 | -1.15 |
| 2024-09-26 | -1.16 |
| 2024-09-25 | -1.17 |
| 2024-09-24 | -1.18 |
| 2024-09-23 | -1.19 |